Epilepsy in the cancer patient Odysseas KargiotisSofia MarkoulaAthanasios P. Kyritsis Mini Review 09 February 2011 Pages: 489 - 501
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination Ramesh K. RamanathanJames AbbruzzeseDaniel D. Von Hoff Original Article 12 May 2010 Pages: 503 - 509
A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas Marisa E. HillXiaobai LiTanios Bekaii-Saab Original Article 12 May 2010 Pages: 511 - 517
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas David GoldsteinM. Corona GainfordJenny Shannon Original Article 12 May 2010 Pages: 519 - 525
Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer Jin Young KimYoung Rok DoHong Suk Song Original Article 12 May 2010 Pages: 527 - 532
Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer Noriyuki MasudaShunichi NegoroMasahiro Fukuoka Original Article Open access 15 May 2010 Pages: 533 - 542
Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice Yongchuan GuChristopher P. GuiseWilliam R. Wilson Original Article 15 May 2010 Pages: 543 - 555
The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid Antonello A. RomaniSilvia DesenzaniPaolo Soliani Original Article 15 May 2010 Pages: 557 - 567
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents Andrew M. GravettWai M. LiuAngus G. Dalgleish Original Article 19 May 2010 Pages: 569 - 577
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN) Eric H. KrautChristopher RhoadesMichael R. Grever Original Article 19 May 2010 Pages: 579 - 586
Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC) Tetsuya HamaguchiKuniaki ShiraoThe NSAS-CC Group Original Article 19 May 2010 Pages: 587 - 596
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect Saik UrienFrançois DozJean-Marc Treluyer Original Article 20 May 2010 Pages: 597 - 603
Noscapine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo Meng LiuXiao-Juan LuoWei-Guo Dong Original Article 21 May 2010 Pages: 605 - 612
Plasma disposition of capecitabine and its metabolites 5′DFCR and 5′DFUR in a standard and dose-intensified monotherapy regimen Martin CzejkaJ. SchuellerW. Scheithauer Original Article 22 May 2010 Pages: 613 - 619
Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas Weijing SunJames M. MetzDaniel G. Haller Original Article 22 May 2010 Pages: 621 - 627
Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases Tatsuro YamaguchiHiroshi MatsumotoKeiichi Takahashi Original Article 22 May 2010 Pages: 629 - 635
In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines Hua ChengShe-Juan AnYi-Long Wu Original Article 22 May 2010 Pages: 637 - 646
Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs Dirk HesheStephanie HoogestraatClaudia Lanvers-Kaminsky Original Article 26 May 2010 Pages: 647 - 655
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma A. I. DaudC. XuV. K. Sondak Original Article Open access 28 May 2010 Pages: 657 - 666
Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists N. Percie du SertJ. A. RuddP. L. R. Andrews Original Article Open access 28 May 2010 Pages: 667 - 686
Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines Patrizia ViciAlessandra FabiMassimo Lopez Original Article 29 May 2010 Pages: 687 - 693
Marginal increase of sunitinib exposure by grapefruit juice Nielka P. van ErpSharyn D. BakerHans Gelderblom Original Article Open access 29 May 2010 Pages: 695 - 703
Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA) Hirak S. BasuAmy MahlumGeorge Wilding Original Article 30 May 2010 Pages: 705 - 715
A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients Satoshi YodaKenzo SoejimaKoichiro Asano Clinical Trial Report 09 December 2010 Pages: 717 - 722
Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization Emiliano S. LopezManglio M. RizzoJuan E. Gallo Short Communication 21 September 2010 Pages: 723 - 728